New paediatric HIV/AIDS centre for Swaziland
This article was originally published in Clinica
Executive Summary
Swaziland's first medical centre dedicated to paediatric HIV/AIDS care is being built in Mbabane. Construction of the centre began officially last week, in a high-profile event attended by Prime Minister Absalom Themba Dlamini and health minister Chief Sipho Shongwe. It is due to open in December 2005. The centre is being funded under Bristol-Myers Squibb's $120m Secure the Future programme, which was established with the aim of supporting HIV care of women and children in sub-Saharan Africa, where there is an estimated 1.9 million HIV-infected under-15s.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.